Now, a large-scale Scandinavian study has found no significant increase in thyroid cancer risk in those taking GLP-1 receptor agonists compared with those on other treatments for type 2 diabetes
And, um, but then as I started to dig into it, I also look at this and go, I think this is the ultimate longevity peptide
If the COA is a vendor-generated PDF with no external lab name and no chromatogram, treat it as unverified
362 In an experimental study in which osteoclast formation and bone resorption were induced in mice through lipopolysaccharide (LPS) administration, researchers discovered that simultaneous treatment with exendin-4 resulted in a significant decrease in the number of osteoclasts, the proportion of bone resorption pits, and the levels of the bone resorption marker CTX compared to injection with LPS alone
The Evolution and Impact of GLP-1 Medications A New Era in Health